You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Reduced cardiorespiratory fitness is a mediator of excess all-cause mortality in rheumatoid arthritis: the Trøndelag Health Study

Article info

Article menu

Download PDFPDF

Rheumatoid arthritis
Original research
Reduced cardiorespiratory fitness is a mediator of excess all-cause mortality in rheumatoid arthritis: the Trøndelag Health Study

Authors

  • Marthe Halsan Liff Clinic of Orthopaedics, Rheumatology and Dermatology, St Olavs University Hospital, Trondheim, NorwayDepartment of Clinical and Molecular Medicine, NTNU - Norwegian University of Science and Technology, Trondheim, Norway PubMed articlesGoogle scholar articles
  • Mari Hoff Department of Neuromedicine and Movement Science, NTNU - Norwegian University of Science and Technology, Trondheim, NorwayDepartment of Rheumatology, St Olavs University Hospital, Trondheim, Norway PubMed articlesGoogle scholar articles
  • Ulrik Wisloff Department of Circulation and Medical Imaging, NTNU - Norwegian University of Science and Technology, Trondheim, NorwaySchool of Human Movement & Nutrition Sciences, The University of Queensland, Saint Lucia, Queensland, Australia PubMed articlesGoogle scholar articles
  • Vibeke Videm Department of Clinical and Molecular Medicine, NTNU - Norwegian University of Science and Technology, Trondheim, NorwayDepartment of Immunology and Transfusion Medicine, St Olavs University Hospital, Trondheim, Norway PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Vibeke Videm; vibeke.videm{at}ntnu.no
View Full Text

Citation

Liff MH, Hoff M, Wisloff U, et al
Reduced cardiorespiratory fitness is a mediator of excess all-cause mortality in rheumatoid arthritis: the Trøndelag Health Study
RMD Open 2021;7:e001545. doi: 10.1136/rmdopen-2020-001545

Publication history

  • Received December 8, 2020
  • Revision received February 8, 2021
  • Accepted February 17, 2021
  • First published March 8, 2021.
Online issue publication 
January 09, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.